Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Endovascular thrombectomy interventions showed no clear difference in symptomatic intracranial haemorrhage at the end of compared with standard therapy (high certainty).
Endovascular thrombectomy interventions probably leads to higher neurological status at the end of compared with standard therapy (moderate certainty).
Endovascular thrombectomy interventions probably leads to higher degree of recanalisation (TIMI grade) compared with standard therapy (moderate certainty).
It is very uncertain whether fluoxetine changes remission (response plus end score 8 or less) compared with light therapy (very low certainty).
The review found no eligible studies for this question.
Fluoxetine showed no clear difference in adverse events (at least 1 treatment‐emergent adverse event) compared with light therapy (low certainty).
Fluoxetine showed no clear difference in response (> 50% improvement on 24‐item HAM‐D SIGH‐SAD) compared with light therapy (low certainty).
The review found no eligible studies for this question.
Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
It is very uncertain whether dopamine agonist plus co‐intervention changes multiple pregnancy rate compared with co‐intervention (very low certainty).
Dopamine agonist plus co‐intervention showed no clear difference in miscarriage rate compared with co‐intervention (low certainty).
It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with other active intervention (moderate certainty).
Dopamine agonist showed no clear difference in multiple pregnancy rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in miscarriage rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with placebo/no intervention (low certainty).